Evidence map›Paper›PMID 33070781›Full record

ArticleBMC cardiovascular disorders2020

Cardiology on the cutting edge: updates from the European Society of Cardiology (ESC) Congress 2020.

Enrique Gallego-Colon, Aldo Bonaventura, Alessandra Vecchié, Antonio Cannatà, Ciarán Martin Fitzpatrick

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Enrique Gallego-ColonCardiology Department, Barzilai University Medical Center, Hahistadrout St 2, 30604, Ashkelon, Israel. enrique.gce@gmail.com.
Aldo BonaventuraPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, 1200 East Marshall Street, Richmond, VA, 23298, USA.
Alessandra VecchiéPauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, 1200 East Marshall Street, Richmond, VA, 23298, USA.
Antonio CannatàDepartment of Cardiovascular Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Ciarán Martin FitzpatrickBMC Series, Springer Nature, 4 Crinan Street, London, N1 9XW, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2020 annual Congress of the European Society of Cardiology (ESC) was the first ever to be held virtually. Under the spotlight of 'the cutting edge of cardiology', exciting and ground-breaking cardiovascular (CV) science was presented both in basic and clinical research. This commentary summarizes essential updates from ESC 2020-The Digital Experience. Despite the challenges that coronavirus disease 2019 (COVID-19) has posed on the conduct of clinical trials, the ESC Congress launched the results of major studies bringing innovation to the field of general cardiology, cardiac surgery, heart failure, interventional cardiology, and atrial fibrillation. In addition to three new ESC guidelines updates, the first ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease were presented. As former ESC president, Professor Casadei undoubtedly pointed out the ESC Congress 2020 was a great success. During the ESC 2020 Congress, BMC Cardiovascular Disorders updated to seven journal sections including Arrhythmias and Electrophysiology, CV Surgery, Coronary Artery Disease, Epidemiology and Digital health, Hypertension and Vascular biology, Primary prevention and CV Risk, and Structural Diseases, Heart Failure, and Congenital Disorders. To conclude, an important take-home message for all CV health care professionals engaged in the COVID-19 pandemic is that we must foresee and be prepared to tackle the dramatic, long-term CV complications of COVID-19 patients.

Indexed as

CardiologyCardiovascular DiseasesCoronavirus InfectionsPandemicsPneumonia, ViralAnnual Reports as TopicBetacoronavirusCongresses as TopicCOVID-19EuropeHumansInfection ControlPractice Guidelines as TopicSARS-CoV-2Societies, MedicalTelecommunicationsAtrial fibrillationCOVID-19ESC CongressESC guidelinesHeart failureHypertensionMyocardial infarctionPulmonary embolism

Identifiers

PMID33070781
PMCPMC7568944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.